ABCELLERA BIOLOGICS INC (ABCL) Stock News
NASDAQ:ABCL - Nasdaq - CA00288U1066 - Common Stock - Currency: USD
ABCL Latest News, Press Relases and Analysis
Omega Healthcare Investors, Inc. (OHI): A Bull Case Theory
We came across a bullish thesis on Omega Healthcare Investors, Inc. (OHI) on Value Investing Subreddit Page by NotFunnyLikeHaHa. In this article, we will summarize the bulls’ thesis on OHI. Omega Healthcare Investors, Inc. (OHI)’s share was trading at $37.42 as of May 19th. OHI’s trailing and forward P/E were 23.24 and 10.13 respectively according to Yahoo […]
Capricor Therapeutics, Inc.’s (CAPR): Analysts See 489% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Capricor Therapeutics, Inc. (NASDAQ:CAPR) was one of the stocks that was covered in that article. Wall Street analysts believe CAPR has a 489% upside potential over the next 12 months. Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a biotechnology company that specializes in developing […]
Perspective Therapeutics, Inc. (CATX): Analysts See 460% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Perspective Therapeutics, Inc. (NYSE:CATX) was one of the stocks that was covered in that article. Wall Street analysts believe CATX has a 460% upside potential over the next 12 months. Perspective Therapeutics, Inc. (NYSE:CATX), a biotechnology company specializing in precision-targeted alpha therapies […]
AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. AbCellera Biologics Inc. (NASDAQ:ABCL) was one of the stocks that was covered in that article. Wall Street analysts believe ABCL has a 474% upside potential over the next 12 months. AbCellera Biologics Inc. (NASDAQ:ABCL) is an AI-powered biotechnology company specializing in antibody […]
Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) was one of the stocks that was covered in that article. Wall Street analysts believe LXRX has a 285% upside potential over the next 12 months. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is a biopharmaceutical company with a pioneering approach […]
Could Altimmune, Inc. (ALT): Analysts See 288% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Altimmune, Inc. (NASDAQ:ALT) was one of the stocks that was covered in that article. Wall Street analysts believe ALT has a 288% upside potential over the next 12 months. Altimmune, Inc.(NASDAQ:ALT) is a clinical-stage biopharmaceutical company. It focuses on developing treatments for […]
AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit
AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 11.76% and 49.82%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: FENC
AbCellera Reports Q1 2025 Business Results
AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?
We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look at where AbCellera Biologics Inc. (NASDAQ:ABCL) stands against other best Canadian penny stocks to invest in now. We define penny stocks as shares trading under $5.00, which usually fall into […]
Is B2Gold Corp. (BTG) the Best Canadian Penny Stock to Invest in Now?
We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look at where B2Gold Corp. (NYSE:BTG) stands against other best Canadian penny stocks to invest in now. We define penny stocks as shares trading under $5.00, which usually fall into the […]
AbCellera to Participate at Upcoming Investor Conferences in May and June
AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript
ABCL earnings call for the period ending December 31, 2024.
AbCellera Reports Full Year 2024 Business Results
AbCellera to Participate at Upcoming Investor Conferences in March
AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
AbCellera to Present at Upcoming Investor Conferences in December and January
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
ABCL earnings call for the period ending September 30, 2024.
AbCellera Reports Q3 2024 Business Results
AbCellera to Present at Upcoming Investor Conferences in November 2024
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
